Comparative and functional genomics of the Mycobacterium tuberculosis complex a

aThis review is based on the 2002 Marjory Stephenson Prize Lecture delivered by the author at the 150th Meeting of the Society for General Microbiology, 9 April 2002.

References

1. Anon 1996; Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group. Lancet 348:17–24 [CrossRef]
   [Google Scholar]
2. Aoyama Y., Horiuchi T., Gotoh O., Noshiro M., Yoshida Y. 1998; CYP51-like gene of Mycobacterium tuberculosis actually encodes a P450 similar to eukaryotic CYP51. J Biochem 124:694–696 [CrossRef]
   [Google Scholar]
3. Bange W. R., Collins F. M., Jacobs W. R. Jr 1999; Survival of mice infected with Mycobacterium smegmatis containing large DNA fragments from Mycobacterium tuberculosis . Tuber Lung Dis 79:171–180 [CrossRef]
   [Google Scholar]
4. Banu S., Honoré N., Saint-Joanis B., Philpott D., Prévost M.-C., Cole S. T. 2002; Are the PE-PGRS proteins of Mycobacterium tuberculosis variable surface antigens?. Mol Microbiol 44:9–19 [CrossRef]
   [Google Scholar]
5. Bardarov S., Kriakov J., Carriere C., Yu S., Vaamonde C., McAdam R., Bloom B. R., Hatfull G. R., Jacobs W. R. Jr 1997; Conditionally replicating mycobacteriophages: a system for transposon delivery to Mycobacterium tuberculosis . Proc Natl Acad Sci USA 94:10961–10966 [CrossRef]
   [Google Scholar]
6. Behr M. A., Wilson M. A., Gill W. P., Salamon H., Schoolnik G. K., Rane S., Small P. M. 1999; Comparative genomics of BCG vaccines by whole-genome DNA microarrays. Science 284:1520–1523 [CrossRef]
   [Google Scholar]
7. Berthet F. X., Rasmussen P. B., Rosenkrandt I., Andersen P., Gicquel B. 1998; A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10). Microbiology 144:3195–3203 [CrossRef]
   [Google Scholar]
8. Betts J. C., Dodson P., Quan S., Lewis A. P., Thomas P. J., Duncan K., McAdam R. A. 2000; Comparison of the proteome of Mycobacterium tuberculosis strain H37Rv with clinical isolate CDC 1551. Microbiology 146:3205–3216
   [Google Scholar]
9. Bloom B. R., Fine P. E. M. 1994; The BCG experience: implications for future vaccines against tuberculosis. In Tuberculosis: Pathogenesis, Protection, and Control pp 531–557 Edited by Bloom B. R. Washington, DC: American Society for Microbiology;
   [Google Scholar]
10. Brennan M. J., Delogu G. 2002; The PE multigene family: a molecular mantra for mycobacteria. Trends Microbiol 10:246–249 [CrossRef]
    [Google Scholar]
11. Brennan M. J., Delogu G., Chen Y., Bardarov S., Kriakov J., Alavi M., Jacobs W. R. Jr 2001; Evidence that mycobacterial PE_PGRS proteins are cell surface constituents that influence interactions with other cells. Infect Immun 69:7326–7333 [CrossRef]
    [Google Scholar]
12. Brodin P., Eiglmeier K., Marmiesse M., Billault A., Garnier T., Niemann S., Cole S. T., Brosch R. 2002; Bacterial Artificial Chromosome-based comparative genomic analysis identifies Mycobacterium microti as a natural ESAT-6 deletion mutant. Infect Immun 70: in press
    [Google Scholar]
13. Brosch R., Gordon S. V., Billault A., Garnier T., Eiglmeier K., Soravito C., Barrell B. G., Cole S. T. 1998; Use of a Mycobacterium tuberculosis H37Rv Bacterial Artificial Chromosome (BAC) library for genome mapping, sequencing and comparative genomics. Infect Immun 66:2221–2229
    [Google Scholar]
14. Brosch R., Philipp W., Stavropolous E., Colston M. J., Cole S. T., Gordon S. V. 1999; Genomic analysis reveals variation between Mycobacterium tuberculosis H37Rv and the attenuated M. tuberculosis H37Ra. Infect Immun 67:5768–5774
    [Google Scholar]
15. Brosch R., Gordon S. V., Eiglmeier K., Garnier T., Tekaia F., Yeramian E., Cole S. T. 2000; Genomics, biology, and evolution of the Mycobacterium tuberculosis complex. In Molecular Genetics of Mycobacteria pp 19–36 Edited by Hatfull G. F., Jacobs W. R. Jr Washington, DC: American Society for Microbiology;
    [Google Scholar]
16. Brosch R., Gordon S. V., Marmiesse M. & 12 other authors; 2002; A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc Natl Acad Sci USA 99:3684–3689 [CrossRef]
    [Google Scholar]
17. Calmette A. 1927 La vaccination préventive contre la tuberculose. Paris: Masson et cie;
    [Google Scholar]
18. Camacho L. R., Ensergueix D., Perez E., Gicquel B., Guilhot C. 1999; Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis. Mol Microbiol 34:257–267 [CrossRef]
    [Google Scholar]
19. Camus J.-C., Pryor M. J., Médigue C., Cole S. T. 2002; Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv. Microbiology 148:2967–2973
    [Google Scholar]
20. Cole S. T. 1999; Learning from the genome sequence of Mycobacterium tuberculosis H37Rv. FEBS Lett 452:7–10 [CrossRef]
    [Google Scholar]
21. Cole S. T. 2002; Comparative mycobacterial genomics as a tool for drug target and antigen discovery. Eur Respir J in press
    [Google Scholar]
22. Cole S. T., Barrell B. G. 1998; Analysis of the genome of Mycobacterium tuberculosis H37Rv. Novartis Found Symp 217:160–172
    [Google Scholar]
23. Cole S. T., Brosch R., Parkhill J. 39 other authors 1998; Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393:537–544 [CrossRef]
    [Google Scholar]
24. Cole S. T., Eiglmeier K., Parkhill J. 42 other authors 2001; Massive gene decay in the leprosy bacillus. Nature 409:1007–1011 [CrossRef]
    [Google Scholar]
25. Daffé M., Draper P. 1998; The envelope layers of mycobacteria with reference to their pathogenicity. Adv Microb Physiol 39:131–203
    [Google Scholar]
26. Delogu G., Brennan M. J. 2001; Comparative immune response to PE and PE_PGRS antigens of Mycobacterium tuberculosis . Infect Immun 69:5606–5611 [CrossRef]
    [Google Scholar]
27. Dye C., Sheele S., Dolin P., Pathania V., Raviglione M. C. 1999; Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. JAMA (J Am Med Assoc) 282:677–686 [CrossRef]
    [Google Scholar]
28. Dye C., Espinal M. A., Watt C. J., Mbiaga C., Williams B. G. 2002; Worldwide incidence of multidrug-resistant tuberculosis. J Infect Dis 185:1197–1202 [CrossRef]
    [Google Scholar]
29. Eiglmeier K., Parkhill J., Honoré N. 12 other authors 2001; The decaying genome of Mycobacterium leprae . Lepr Rev 72:387–398
    [Google Scholar]
30. Espinal M. A., Dye C., Raviglione M., Kochi A. 1999; Rational ‘DOTS plus’ for the control of MDR-TB. Int J Tuberc Lung Dis 3:561–563
    [Google Scholar]
31. Espitia C., Laclette J. P., Mondragon-Palomino M. 7 other authors 1999; The PE-PGRS glycine-rich proteins of Mycobacterium tuberculosis : a new family of fibronectin-binding proteins?. Microbiology 145:3487–3495
    [Google Scholar]
32. Fine P. E. M. 1995; Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346:1339–1345 [CrossRef]
    [Google Scholar]
33. Gordon S. V., Brosch R., Billault A., Garnier T., Eiglmeier K., Cole S. T. 1999a; Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays. Mol Microbiol 32:643–656 [CrossRef]
    [Google Scholar]
34. Gordon S. V., Heym B., Parkhill J., Barrell B., Cole S. T. 1999b; New insertion sequences and a novel repeated sequence in the genome of Mycobacterium tuberculosis H37Rv. Microbiology 145:881–892 [CrossRef]
    [Google Scholar]
35. Gordon S. V., Eiglmeier K., Garnier T., Brosch R., Parkhill J., Barrell B., Cole S. T., Hewinson R. G. 2001a; Genomics of Mycobacterium bovis . Tuberculosis (Edinb 81:157–163 [CrossRef]
    [Google Scholar]
36. Gordon S. V., Eiglmeier K., Garnier T., Parkhill J., Barrell B., Cole S. T., Hewinson R. G. 2001b; Genomics of Mycobacterium bovis . Tuber Lung Dis 6:157–163
    [Google Scholar]
37. Haas F., Haas S. S. 1996; The origins of Mycobacterium tuberculosis and the notion of its contagiousness. In Tuberculosis pp 4–19 Edited by Rom W. N., Garay S. Boston: Little, Brown and Company;
    [Google Scholar]
38. Harboe M., Oettinger T., Wiker H. G., Rosenkrands I., Andersen P. 1996; Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect Immun 64:16–22
    [Google Scholar]
39. Hart P. D., Sutherland I. 1977; BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Br Med J 2:293–295 [CrossRef]
    [Google Scholar]
40. Hermans P. W. M., van Soolingen D., van Embden J. D. A. 1992; Characterization of a major polymorphic tandem repeat in Mycobacterium tuberculosis and its potential use in the epidemiology of Mycobacterium kansasii and Mycobacterium gordonae . J Bacteriol 174:4157–4165
    [Google Scholar]
41. Hinds J., Mahenthiralingam E., Kempsell K. E., Duncan K., Stokes R. W., Parish T., Stoker N. G. 1999; Enhanced gene replacement in mycobacteria. Microbiology 145:519–527 [CrossRef]
    [Google Scholar]
42. Ho T. B. L., Robertson B. D., Taylor G. M., Shaw R. J., Young D. B. 2001; Comparison of Mycobacterium tuberculosis genomes reveals frequent deletions in a 20 kb variable region in clinical isolates. Yeast 17:272–282
    [Google Scholar]
43. Hondalus M. K., Bardarov S., Russell R., Chan J., Jacobs W. R. Jr, Bloom B. R. 2000; Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis . Infect Immun 68:2888–2898 [CrossRef]
    [Google Scholar]
44. Imaeda T. 1985; Deoxyribonucleic acid relatedness among selected strains of Mycobacterium tuberculosis , Mycobacterium bovis , Mycobacterium bovis BCG, Mycobacterium micoti and Mycobacterium africanum . Int J Syst Bacteriol 35:147–150 [CrossRef]
    [Google Scholar]
45. Jackson M., Phalen S. W., Lagranderie M., Ensergueix D., Chavarot P., Marchal G., McMurray D. N., Gicquel B., Guilhot C. 1999; Persistence and protective efficacy of a Mycobacterium tuberculosis auxotroph vaccine. Infect Immun 67:2867–2873
    [Google Scholar]
46. Jacobs W. R. Jr, Kalpana G. V., Cirillo J. D., Pascopella L., Snapper S. B., Udani R. A., Jones W., Barletta R. G., Bloom B. R. 1991; Genetic systems for mycobacteria. Methods Enzymol 204:537–555
    [Google Scholar]
47. Kapur V., Whittam T. S., Musser J. 1994; Is Mycobacterium tuberculosis 15,000 years old?. J Infect Dis 170:1348–1349 [CrossRef]
    [Google Scholar]
48. Kato-Maeda M., Rhee J. T., Gingeras T. R., Salamon H., Drenkow J., Smittipat N., Small P. M. 2001; Comparing genomes within the species Mycobacterium tuberculosis . Genome Res 11:547–554 [CrossRef]
    [Google Scholar]
49. Koch R. 1882; Die Aetiogie der Tuberculose. Berl Klin Wochenschr 19:221–230
    [Google Scholar]
50. Lillebaek T., Dirksen A., Baess I., Strunge B., Thomsen V. O., Andersen A. B. 2002; Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection. J Infect Dis 185:401–404 [CrossRef]
    [Google Scholar]
51. Mahairas G. G., Sabo P. J., Hickey M. J., Singh D. C., Stover C. K. 1996; Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis . J Bacteriol 178:1274–1282
    [Google Scholar]
52. Munro A. W., Lindsay J. G. 1996; Bacterial cytochromes P-450. Mol Microbiol 20:1115–1125 [CrossRef]
    [Google Scholar]
53. Murray J. R. 1990; Cursed duet: HIV-infection and tuberculosis. Respiration 57:210–220 [CrossRef]
    [Google Scholar]
54. Parish T., Stoker N. G. 2000; Use of a flexible cassette method to generate a double unmarked Mycobacterium tuberculosis tlyA plcABC mutant by gene replacement. Microbiology 146:1969–1975
    [Google Scholar]
55. Pelicic V., Jackson M., Reyrat J. M., Jacobs W. R. Jr, Gicquel B., Guilhot C. 1997; Efficient allelic exchange and transposon mutagenesis in Mycobacterium tuberculosis . Proc Natl Acad Sci USA 94:10955–10960 [CrossRef]
    [Google Scholar]
56. Philipp W. J., Poulet S., Eiglmeier K. 7 other authors 1996; An integrated map of the genome of the tubercle bacillus, Mycobacterium tuberculosis H37Rv, and comparison with Mycobacterium leprae . Proc Natl Acad Sci USA 93:3132–3137 [CrossRef]
    [Google Scholar]
57. Poulet S., Cole S. T. 1995a; Characterisation of the polymorphic GC-rich repetitive sequence (PGRS) present in Mycobacterium tuberculosis . Arch Microbiol 163:87–95 [CrossRef]
    [Google Scholar]
58. Poulet S., Cole S. T. 1995b; Repeated DNA sequences in mycobacteria. Arch Microbiol 163:79–86 [CrossRef]
    [Google Scholar]
59. Ramakrishnan L., Federspiel N. A., Falkow S. 2000; Granuloma-specific expression of mycobacterium virulence proteins from the glycine-rich PE-PGRS family. Science 288:1436–1439 [CrossRef]
    [Google Scholar]
60. Salamon H., Kato-Maeda M., Small P. M., Drenkow J., Gingeras T. R. 2000; Detection of deleted genomic DNA using a semiautomated computational analysis of GeneChip data. Genome Res 10:2044–2054 [CrossRef]
    [Google Scholar]
61. Salo W. L., Aufderheide A. C., Buikstra J., Holcomb T. A. 1994; Identification of Mycobacterium tuberculosis DNA in a pre-Columbian Peruvian mummy. Proc Natl Acad Sci USA 91:2091–2094 [CrossRef]
    [Google Scholar]
62. Sampson S. L., Lukey P., Warren R. M., van Helden P. D., Richardson M., Everett M. J. 2001; Expression, characterization and subcellular localization of the Mycobacterium tuberculosis PPE gene Rv1917c. Tuberculosis (Edinb) 81:305–317 [CrossRef]
    [Google Scholar]
63. Scorpio A., Zhang Y. 1996; Mutations in pncA , a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat Med 2:662–667 [CrossRef]
    [Google Scholar]
64. Singh K. K., Zhang X., Patibandla A. S., Chien P. Jr, Laal S. 2001; Antigens of Mycobacterium tuberculosis expressed during preclinical tuberculosis: serological immunodominance of proteins with repetitive amino acid sequences. Infect Immun 69:4185–4191 [CrossRef]
    [Google Scholar]
65. Sorensen A. L., Nagai S., Houen G., Andersen P., Andersen A. B. 1995; Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis . Infect Immun 63:1710–1717
    [Google Scholar]
66. Sreevatsan S., Pan X., Stockbauer K. E., Connell N. D., Kreiswirth B. N., Whittam T. S., Musser J. M. 1997; Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. Proc Natl Acad Sci USA 94:9869–9874 [CrossRef]
    [Google Scholar]
67. Steenken W. Jr, Gardner L. U. 1946; History of H37 strain of tubercle bacillus. Am Rev Tuberc 54:62–66
    [Google Scholar]
68. Stover C. K., De la Cruz V. F., Fuerst T. R. 11 other authors 1991; New use of BCG for recombinant vaccines. Nature 351:456–460 [CrossRef]
    [Google Scholar]
69. Stover C. K., de la Cruz V. F., Bansal G. P., Hanson M. S., Fuerst T. R., Jacobs W. R. Jr, Bloom B. R. 1992; Use of recombinant BCG as a vaccine delivery vehicle. Adv Exp Med Biol 327:175–182
    [Google Scholar]
70. Tekaia F., Gordon S. V., Garnier T., Brosch R., Barrell B. G., Cole S. T. 1999; Analysis of the proteome of Mycobacterium tuberculosis in silico . Tuber Lung Dis 79:329–342 [CrossRef]
    [Google Scholar]
71. van Soolingen D., de Haas P. E. W., Hermans P. W. M., Groenen P. M. A., van Embden J. D. A. 1993; Comparison of various repetitive DNA elements as genetic markers for strain differentiation and epidemiology of Mycobacterium tuberculosis . J Clin Microbiol 31:1987–1995
    [Google Scholar]
72. Wells A. Q. 1937; Tuberculosis in wild voles. Lancet 232:1221
    [Google Scholar]
73. Wheeler P. R., Ratledge C. 1994; Metabolism of Mycobacterium tuberculosis . In Tuberculosis: Pathogenesis, Protection, and Control pp 353–385 Edited by Bloom B. R. Washington, DC: American Society for Microbiology;
    [Google Scholar]
74. Zhang Y., Young D. B. 1994; Strain variation in the katG region of Mycobacterium tuberculosis . Mol Microbiol 14:301–308 [CrossRef]
    [Google Scholar]